What Schedule III Means for Florida Medical Cannabis PatientsThe Department of Justice and DEA’s decision to place state-licensed medical marijuana products into Schedule III marks a significant shift for patients, but what matters most is how this change improves access to safe, effective, and affordable medicine. […]
Industry Advocate Calls for Patient-Centered Reforms to Florida’s Medical Cannabis Program FOR IMMEDIATE RELEASE West Palm Beach, FL — March 30, 2026 A Florida-based industry professional and patient advocate is urging the Florida Department of Health (DOH) and the Office of Medical Marijuana Use (OMMU) to reevaluate key […]
CMS to Cover Hemp Products? What the New $500 Reimbursement Policy Means CMS Signals Shift: Up to $500 in Approved Hemp Products May Be CoveredA significant policy shift appears to be emerging at the federal level, with Centers for Medicare & Medicaid Services (CMS) signaling potential […]